{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:27:22Z","timestamp":1790807242859,"version":"4.1.0"},"reference-count":49,"publisher":"Japan Atherosclerosis Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.5551\/jat.48603","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T18:03:35Z","timestamp":1558375415000},"page":"592-600","source":"Crossref","is-referenced-by-count":37,"title":["The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials"],"prefix":"10.5551","volume":"26","author":[{"given":"Hiroyuki","family":"Daida","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomotaka","family":"Dohi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Ohmura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Writing Group M, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, American Heart Association Statistics C and Stroke Statistics S: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation, 2016; 133: e38-360","DOI":"10.1161\/CIR.0000000000000350"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S and Murphy A: Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol, 2010; 35: 72-115","DOI":"10.1016\/j.cpcardiol.2009.10.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Mathers CD and Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 2006; 3: e442","DOI":"10.1371\/journal.pmed.0030442"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schun kert H, Watts GF, Boren J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Sluis B, Taskinen MR, Tokgozoglu L, Landmesser U, Laufs U, Wiklund O, Stock JK, Chapman MJ and Catapano AL: Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J, 2017; 38: 2459-2472","DOI":"10.1093\/eurheartj\/ehx144"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Esrey KL, Joseph L and Grover SA: Relationship between dietary intake and coronary heart disease mortality: lipid research clinics prevalence follow-up study. J Clin Epidemiol, 1996; 49: 211-216","DOI":"10.1016\/0895-4356(95)00066-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE, Edmiston WA, Smink RD, Jr. and et al.: Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med, 1990; 323: 946-955","DOI":"10.1056\/NEJM199010043231404"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Gragnano F and Calabro P: Role of dual lipid-lowering therapy in coronary atherosclerosis regression: Evidence from recent studies. Atherosclerosis, 2018; 269: 219-228","DOI":"10.1016\/j.atherosclerosis.2018.01.012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Aikawa M, Rabkin E, Okada Y, Voglic SJ, Clinton SK, Brinckerhoff CE, Sukhova GK and Libby P: Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation, 1998; 97: 2433-2444","DOI":"10.1161\/01.CIR.97.24.2433"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Badimon JJ, Badimon L and Fuster V: Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest, 1990; 85: 1234-1241","DOI":"10.1172\/JCI114558"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Brown BG, Zhao XQ, Sacco DE and Albers JJ: Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation, 1993; 87: 1781-1791","DOI":"10.1161\/01.CIR.87.6.1781"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Feig JE: Regression of atherosclerosis: insights from animal and clinical studies. Ann Glob Health, 2014; 80: 13-23","DOI":"10.1016\/j.aogh.2013.12.001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Farmer JA and Gotto AM, Jr.: Dyslipidemia and the vulnerable plaque. Progress in cardiovascular diseases, 2002; 44: 415-428","DOI":"10.1053\/pcad.2002.123474"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Bang HO and Dyerberg J: Personal reflections on the incidence of ischaemic heart disease in Oslo during the Second World War. Acta Med Scand, 1981; 210: 245-248","DOI":"10.1111\/j.0954-6820.1981.tb09810.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP and Cashin-Hemphill L: Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. Jama, 1987; 257: 3233-3240","DOI":"10.1001\/jama.257.23.3233"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao XQ, Bisson BD, Fitzpatrick VF and Dodge HT: Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med, 1990; 323: 1289-1298","DOI":"10.1056\/NEJM199011083231901"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J and Nilsson J: Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation, 2001; 103: 926-933","DOI":"10.1161\/01.CIR.103.7.926"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC and Havel RJ: Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. Jama, 1990; 264: 3007-3012","DOI":"10.1001\/jama.264.23.3007"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM and Yock PG: American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. Journal of the American College of Cardiology, 2001; 37: 1478-1492","DOI":"10.1016\/S0735-1097(01)01175-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Gogas BD, Farooq V, Serruys PW and Garcia-Garcia HM: Assessment of coronary atherosclerosis by IVUS and IVUS-based imaging modalities: progression and regression studies, tissue composition and beyond. The international journal of cardiovascular imaging, 2011; 27: 225-237","DOI":"10.1007\/s10554-010-9791-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Garcia-Garcia HM, Gogas BD, Serruys PW and Bruining N: IVUS-based imaging modalities for tissue characterization: similarities and differences. The international journal of cardiovascular imaging, 2011; 27: 215-224","DOI":"10.1007\/s10554-010-9789-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Takagi T, Yoshida K, Akasaka T, Hozumi T, Morioka S and Yoshikawa J: Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin. Am J Cardiol, 1997; 79: 1673-1676","DOI":"10.1016\/S0002-9149(97)00221-X"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Matsuzaki M, Hiramori K, Imaizumi T, Kitabatake A, Hishida H, Nomura M, Fujii T, Sakuma I, Fukami K, Honda T, Ogawa H and Yamagishi M: Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART). Journal of the American College of Cardiology, 2002; 40: 220-227","DOI":"10.1016\/S0735-1097(02)01955-1"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Schartl M, Bocksch W, Koschyk DH, Voelker W, Karsch KR, Kreuzer J, Hausmann D, Beckmann S and Gross M: Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation, 2001; 104: 387-392","DOI":"10.1161\/hc2901.093188"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN and Investigators R: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. Jama, 2004; 291: 1071-1080","DOI":"10.1001\/jama.291.9.1071"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM and Investigators A: Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. Jama, 2006; 295: 1556-1565","DOI":"10.1001\/jama.295.13.jpc60002"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H and Daida H: Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation, 2004; 110: 1061-1068","DOI":"10.1161\/01.CIR.0000140261.58966.A4"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, Yamaguchi T, Daida H, Matsuzaki M and Investigators J-A: Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). Journal of the American College of Cardiology, 2009; 54: 293-302","DOI":"10.1161\/circ.118.suppl_18.S_657-c"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Takayama T, Hiro T, Yamagishi M, Daida H, Hirayama A, Saito S, Yamaguchi T, Matsuzaki M and Investigators C: Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Circ J, 2009; 73: 2110-2117","DOI":"10.1253\/circj.CJ-09-0358"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, Raichlen JS, Uno K, Borgman M, Wolski K and Nissen SE: Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med, 2011; 365: 2078-2087","DOI":"10.1056\/NEJMoa1110874"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H and Investigators P-I: Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISEIVUS Trial. Journal of the American College of Cardiology, 2015; 66: 495-507","DOI":"10.1016\/j.jacc.2015.05.065"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Nicholls SJ, Puri R, Anderson T, Ballantyne CM, Cho L, Kastelein JJ, Koenig W, Somaratne R, Kassahun H, Yang J, Wasserman SM, Scott R, Ungi I, Podolec J, Ophuis AO, Cornel JH, Borgman M, Brennan DM and Nissen SE: Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial. Jama, 2016; 316: 2373-2384","DOI":"10.1001\/jama.2016.16951"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Kolodgie FD, Burke AP, Farb A, Gold HK, Yuan J, Narula J, Finn AV and Virmani R: The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol, 2001; 16: 285-292","DOI":"10.1097\/00001573-200109000-00006"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Verhoeven BA, Moll FL, Koekkoek JA, van der Wal AC, de Kleijn DP, de Vries JP, Verheijen JH, Velema E, Busser E, Schoneveld A, Virmani R and Pasterkamp G: Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy. Stroke; a journal of cerebral circulation, 2006; 37: 2054-2060","DOI":"10.1161\/01.STR.0000231685.82795.e5"},{"key":"34","unstructured":"34) Hartung D, Sarai M, Petrov A, Kolodgie F, Narula N, Verjans J, Virmani R, Reutelingsperger C, Hofstra L and Narula J: Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. J Nucl Med, 2005; 46: 2051-2056"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Kawasaki M, Sano K, Okubo M, Yokoyama H, Ito Y, Murata I, Tsuchiya K, Minatoguchi S, Zhou X, Fujita H and Fujiwara H: Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. Journal of the American College of Cardiology, 2005; 45: 1946-1953","DOI":"10.1016\/j.jacc.2004.09.081"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Nasu K, Tsuchikane E, Katoh O, Tanaka N, Kimura M, Ehara M, Kinoshita Y, Matsubara T, Matsuo H, Asakura K, Asakura Y, Terashima M, Takayama T, Honye J, Hirayama A, Saito S and Suzuki T: Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound. JACC Cardiovascular interventions, 2009; 2: 689-696","DOI":"10.1016\/j.jcin.2009.04.016"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Park SJ, Kang SJ, Ahn JM, Chang M, Yun SC, Roh JH, Lee PH, Park HW, Yoon SH, Park DW, Lee SW, Kim YH, Lee CW, Mintz GS, Han KH and Park SW: Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study. Journal of the American College of Cardiology, 2016; 67: 1772-1783","DOI":"10.1016\/j.jacc.2016.02.014"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Yokoyama M, Komiyama N, Courtney BK, Nakayama T, Namikawa S, Kuriyama N, Koizumi T, Nameki M, Fitzgerald PJ and Komuro I: Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study. Am Heart J, 2005; 150: 287","DOI":"10.1016\/j.ahj.2005.03.059"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Hong MK, Park DW, Lee CW, Lee SW, Kim YH, Kang DH, Song JK, Kim JJ, Park SW and Park SJ: Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis. JACC Cardiovascular interventions, 2009; 2: 679-688","DOI":"10.1016\/j.jcin.2009.03.015"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Toi T, Taguchi I, Yoneda S, Kageyama M, Kikuchi A, Tokura M, Kanaya T, Abe S, Matsuda R and Kaneko N: Early effect of lipid-lowering therapy with pitavastatin on regression of coronary atherosclerotic plaque. Comparison with atorvastatin. Circ J, 2009; 73: 1466-1472","DOI":"10.1253\/circj.CJ-08-1051"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Nozue T, Yamamoto S, Tohyama S, Umezawa S, Kunishima T, Sato A, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Sozu T, Terashima M and Michishita I: Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis. Am Heart J, 2012; 163: 191-199 e191","DOI":"10.1016\/j.ahj.2011.11.004"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Lee SW, Hau WK, Kong SL, Chan KK, Chan PH, Lam SC, Tam FC, Wong MK, Chan CW, Lam YM, Tse HF and Chan RH: Virtual histology findings and effects of varying doses of atorvastatin on coronary plaque volume and composition in statin-naive patients: the VENUS study. Circ J, 2012; 76: 2662-2672","DOI":"10.1253\/circj.CJ-12-0325"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Hattori K, Ozaki Y, Ismail TF, Okumura M, Naruse H, Kan S, Ishikawa M, Kawai T, Ohta M, Kawai H, Hashimoto T, Takagi Y, Ishii J, Serruys PW and Narula J: Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. JACC Cardiovasc Imaging, 2012; 5: 16-177","DOI":"10.1016\/j.jcmg.2011.11.012"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Nicholls SJ, Hsu A, Wolski K, Hu B, Bayturan O, Lavoie A, Uno K, Tuzcu EM and Nissen SE: Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. Journal of the American College of Cardiology, 2010; 55: 2399-2407","DOI":"10.1016\/j.jacc.2010.02.026"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Dohi T, Miyauchi K, Okazaki S, Yokoyama T, Yanagisawa N, Tamura H, Kojima T, Yokoyama K, Kurata T and Daida H: Plaque regression determined by intravascular ultrasound predicts long-term outcomes of patients with acute coronary syndrome. J Atheroscler Thromb, 2011; 18: 231-239","DOI":"10.5551\/jat.6551"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM and Investigators I-I: Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med, 2015; 372: 2387-2397","DOI":"10.1056\/NEJMoa1410489"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR, Committee FS and Investigators: Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med, 2017; 376: 1713-1722","DOI":"10.1056\/NEJMoa1615664"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Chistiakov DA, Myasoedova VA, Revin VV, Orekhov AN and Bobryshev YV: The phenomenon of atherosclerosis reversal and regression: Lessons from animal models. Exp Mol Pathol, 2017; 102: 138-145","DOI":"10.1016\/j.yexmp.2017.01.013"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Nakajima N, Miyauchi K, Yokoyama T, Ogita M, Miyazaki T, Tamura H, Nishino A, Yokoyama K, Okazaki S, Kurata T, Suwa S, Daida H: Effect of combination of ezetimibe and a statin on coronary plaque regression in patients with acute coronary syndrome: ZEUS trial (eZEtimibe Ultrasound Study). IJC Metabolic &amp; Endocrine, 2014; 3: 8-13","DOI":"10.1016\/j.ijcme.2014.03.001"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/26\/7\/26_48603\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T05:26:53Z","timestamp":1663478813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/26\/7\/26_48603\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.48603","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}